Literature DB >> 30929270

Low dose positron emission tomography emulation from decimated high statistics: A clinical validation study.

Josh Schaefferkoetter1,2,3, Ying-Hwey Nai1, Anthonin Reilhac1, David William Townsend1, Lars Eriksson4, Maurizio Conti4.   

Abstract

PURPOSE: The fundamental nature of positron emission tomography (PET), as an event detection system, provides some flexibility for data handling, including retrospective data manipulation. The reorganization of acquisition data allows the emulation of new scans arising from identical radiotracer spatial distributions, but with different statistical compositions, and is especially useful for evaluating the stability and reproducibility of reconstruction algorithms or when investigating extremely low count conditions. This approach is ubiquitous in the research literature but has only been validated, from the point of view of the noise properties, with numerical simulations and phantom data. We present here the first experiment comparing PET images of the same human subjects generated with two separate injections of radiotracer, using actual low dose (LD) data to validate a randomly decimated emulation from a standard dose scan. A key point of the work is focused on the randoms fractions, which scale differently than the trues at varying activity levels.
METHODS: Eleven patients with non-small cell lung cancer were enrolled in the study. Each imaging session consisted of two independent FDG-PET/CT scans: a LD scan followed by a standard dose (SD) scan. Images were first reconstructed, using filtered back-projection (FBP) and OSEM incorporating time-of-flight information and point-spread function modeling (PSFTOF), from the LD and SD datasets comprising all counts from each scanned bed position. The number of true counts was recorded for all LD scans, and independent, count-matched emulations (ELD) were reconstructed from the SD data. Noise distribution within the liver and standardized uptake value reproducibility within a population of contoured, tracer-avid lesion volumes were evaluated across scans and statistics.
RESULTS: The randoms fraction estimates were 17.4 ± 1.6% (14.9-19.4) in the LD data and 42 ± 2.3% (37.1-45.5) in the SD data. Eleven lesions were identified and volumes of interest were generated with a 50% threshold isocontour for each lesion, in every image. The distributions of metabolic volumes, means and maxima defined by the contoured volumes-of-interest (VOIs) were similar between the LD and SD sets. A two-tailed, matched t-test was performed on the populations of region statistics for both LD and ELD reconstructions, and the t-statistics were 1.1 (P = 0.267) and -0.22 (P = 0.828) for the background liver VOIs and -0.54 (P = 0.603) and 0.23 (P = 0.821) for the lesion VOIs, for FBP and PSFTOF respectively. In every test, the null hypothesis that the two populations had the same mean could not be rejected at the 5% significance level.
CONCLUSIONS: Our results demonstrate that clinical LD PET scans can indeed be accurately emulated by the statistical decimation of standard dose scans, and this was achieved through validation by images generated with unbiased random coincidence estimations.
© 2019 American Association of Physicists in Medicine.

Entities:  

Keywords:  emulation; listmode; low dose PET

Mesh:

Year:  2019        PMID: 30929270     DOI: 10.1002/mp.13517

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  9 in total

1.  A personalized deep learning denoising strategy for low-count PET images.

Authors:  Qiong Liu; Hui Liu; Niloufar Mirian; Sijin Ren; Varsha Viswanath; Joel Karp; Suleman Surti; Chi Liu
Journal:  Phys Med Biol       Date:  2022-07-13       Impact factor: 4.174

2.  True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation.

Authors:  Kevin T Chen; Tyler N Toueg; Mary Ellen Irene Koran; Guido Davidzon; Michael Zeineh; Dawn Holley; Harsh Gandhi; Kim Halbert; Athanasia Boumis; Gabriel Kennedy; Elizabeth Mormino; Mehdi Khalighi; Greg Zaharchuk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-08       Impact factor: 9.236

3.  Projection Space Implementation of Deep Learning-Guided Low-Dose Brain PET Imaging Improves Performance over Implementation in Image Space.

Authors:  Amirhossein Sanaat; Hossein Arabi; Ismini Mainta; Valentina Garibotto; Habib Zaidi
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 11.082

4.  The role of activity, scan duration and patient's body mass index in the optimization of FDG imaging protocols on a TOF-PET/CT scanner.

Authors:  Roberta Matheoud; Naema Al-Maymani; Alessia Oldani; Gian Mauro Sacchetti; Marco Brambilla; Alessandro Carriero
Journal:  EJNMMI Phys       Date:  2021-04-06

5.  Impact of low injected activity on data driven respiratory gating for PET/CT imaging with continuous bed motion.

Authors:  Joseph G Meier; Radwan H Diab; Trevor M Connor; Osama R Mawlawi
Journal:  J Appl Clin Med Phys       Date:  2022-04-28       Impact factor: 2.243

6.  Evaluation of a High-Sensitivity Organ-Targeted PET Camera.

Authors:  Justin Stiles; Brandon Baldassi; Oleksandr Bubon; Harutyun Poladyan; Vivianne Freitas; Anabel Scaranelo; Anna Marie Mulligan; Michael Waterston; Alla Reznik
Journal:  Sensors (Basel)       Date:  2022-06-21       Impact factor: 3.847

7.  Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.

Authors:  Marine Soret; Jacques-Antoine Maisonobe; Serge Desarnaud; Sébastien Bergeret; Valérie Causse-Lemercier; Arnaud Berenbaum; Laura Rozenblum; Marie-Odile Habert; Aurélie Kas
Journal:  Sci Rep       Date:  2022-09-12       Impact factor: 4.996

Review 8.  Applications of artificial intelligence and deep learning in molecular imaging and radiotherapy.

Authors:  Hossein Arabi; Habib Zaidi
Journal:  Eur J Hybrid Imaging       Date:  2020-09-23

9.  Reducing Radiation Exposure to Paediatric Patients Undergoing [18F]FDG-PET/CT Imaging.

Authors:  Hunor Kertész; Thomas Beyer; Kevin London; Hamda Saleh; David Chung; Ivo Rausch; Jacobo Cal-Gonzalez; Theo Kitsos; Peter L Kench
Journal:  Mol Imaging Biol       Date:  2021-04-12       Impact factor: 3.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.